Insider Transactions in Q1 2025 at Mgp Ingredients Inc (MGPI)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2025
|
Todd B. Siwak Director |
SELL
Open market or private sale
|
Indirect |
653
-17.65%
|
$19,590
$30.67 P/Share
|
|
Mar 13
2025
|
Karen Seaberg Director |
SELL
Open market or private sale
|
Indirect |
28,304
-2.93%
|
$849,120
$30.76 P/Share
|
|
Mar 12
2025
|
Karen Seaberg Director |
SELL
Open market or private sale
|
Indirect |
39,404
-2.85%
|
$1,182,120
$30.57 P/Share
|
|
Mar 12
2025
|
Erika Lapish Vice President & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
2,156
+16.23%
|
-
|
|
Mar 12
2025
|
Amel Pasagic Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,799
+17.6%
|
-
|
|
Mar 12
2025
|
Brandon Gall Interim President & CEO; CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,802
+7.87%
|
-
|
|
Mar 11
2025
|
Donn S. Lux |
SELL
Open market or private sale
|
Indirect |
100,000
-1.91%
|
$3,100,000
$31.92 P/Share
|
|
Mar 11
2025
|
Karen Seaberg Director |
SELL
Open market or private sale
|
Indirect |
135,533
-1.24%
|
$4,337,056
$32.04 P/Share
|
|
Mar 11
2025
|
Karen Seaberg Director |
SELL
Open market or private purchase
|
Indirect |
8,028
-2.24%
|
$248,868
$31.51 P/Share
|
|
Mar 11
2025
|
Karen Seaberg Director |
BUY
Open market or private purchase
|
Indirect |
5,348
+1.47%
|
$171,136
$32.59 P/Share
|
|
Mar 10
2025
|
Karen Seaberg Director |
SELL
Open market or private sale
|
Indirect |
20,874
-2.1%
|
$709,716
$34.27 P/Share
|
|
Mar 10
2025
|
Lori L.S. Mingus Director |
SELL
Open market or private sale
|
Indirect |
9,464
-25.32%
|
$321,776
$34.52 P/Share
|
|
Feb 14
2025
|
Brandon Gall Interim President & CEO; CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,072
-2.04%
|
$35,376
$33.15 P/Share
|
|
Feb 14
2025
|
Erika Lapish Vice President & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
553
-5.81%
|
$18,249
$33.15 P/Share
|
|
Feb 14
2025
|
Amel Pasagic Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
575
-5.28%
|
$18,975
$33.15 P/Share
|
|
Feb 12
2025
|
Brandon Gall Interim President & CEO; CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,908
-3.51%
|
$59,148
$31.84 P/Share
|
|
Feb 10
2025
|
Brandon Gall Interim President & CEO; CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,843
-3.28%
|
$58,976
$32.64 P/Share
|
|
Feb 10
2025
|
Erika Lapish Vice President & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
818
-7.91%
|
$26,176
$32.64 P/Share
|
|
Feb 10
2025
|
Amel Pasagic Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
793
-6.79%
|
$25,376
$32.64 P/Share
|
|
Jan 02
2025
|
Preet H. Michelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
476
+8.78%
|
$18,564
$39.37 P/Share
|
|
Jan 02
2025
|
Todd B. Siwak Director |
BUY
Grant, award, or other acquisition
|
Direct |
476
+33.19%
|
$18,564
$39.37 P/Share
|
|
Jan 02
2025
|
Thomas A Gerke Director |
BUY
Grant, award, or other acquisition
|
Direct |
539
+6.89%
|
$21,021
$39.37 P/Share
|
|
Jan 01
2025
|
Brandon Gall Interim President & CEO; CFO |
BUY
Grant, award, or other acquisition
|
Direct |
13,335
+19.17%
|
-
|